Copyright
©The Author(s) 2016.
World J Gastroenterol. Dec 14, 2016; 22(46): 10198-10209
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10198
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10198
Figure 5 Final diagnosis for symptomatic patients without nodular lymphoid hyperplasia.
IBS: Irritable bowel syndrome; IBS-M: IBS mixed bowel habit; IBS-C: IBS with prevalent constipation; IBS-D: IBS with prevalent diarrhoea; IBD: Inflammatory bowel disease.
- Citation: Piscaglia AC, Laterza L, Cesario V, Gerardi V, Landi R, Lopetuso LR, Calò G, Fabbretti G, Brisigotti M, Stefanelli ML, Gasbarrini A. Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? World J Gastroenterol 2016; 22(46): 10198-10209
- URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10198.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10198